Brief: Immunoprecise Antibodies Ltd. Divests Netherlands Facilities To AVS Bio
06/08/2025 13:38
Aug 6 (Reuters) - Immunoprecise Antibodies Ltd IPA.O: IMMUNOPRECISE ANTIBODIES LTD. DIVESTS NETHERLANDS FACILITIES TO AVS BIO TO ACCELERATE BIO-NATIVE AI INNOVATION IMMUNOPRECISE ANTIBODIES LTD - SELLS NETHERLANDS SUBSIDIARY TO AVS BIO FOR $12 MILLION IMMUNOPRECISE ANTIBODIES LTD - PROCEEDS TO SUPPORT INVESTMENT IN SCIENTIFIC PLATFORMS Source text: ID:nBw5qp0W8a Further company coverage: IPA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai